Rhumbline Advisers Sells 36,908 Shares of Arteris, Inc. (NASDAQ:AIP)

Rhumbline Advisers trimmed its holdings in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) by 47.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,066 shares of the company's stock after selling 36,908 shares during the period. Rhumbline Advisers owned about 0.10% of Arteris worth $277,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. G2 Investment Partners Management LLC bought a new position in shares of Arteris in the fourth quarter worth approximately $2,799,000. Charles Schwab Investment Management Inc. boosted its position in Arteris by 4.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company's stock valued at $802,000 after buying an additional 3,298 shares during the period. BNP Paribas Financial Markets bought a new stake in Arteris in the 4th quarter worth $214,000. Two Sigma Advisers LP grew its holdings in Arteris by 82.9% in the 4th quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock worth $240,000 after acquiring an additional 10,700 shares during the last quarter. Finally, EAM Investors LLC purchased a new position in shares of Arteris in the fourth quarter valued at about $983,000. 64.36% of the stock is owned by institutional investors.

Arteris Trading Up 1.1%

Shares of AIP traded up $0.11 during mid-day trading on Friday, hitting $9.69. 1,657,907 shares of the company's stock traded hands, compared to its average volume of 223,655. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $12.64. The firm has a market capitalization of $406.79 million, a P/E ratio of -11.82 and a beta of 1.37. The business's 50-day moving average price is $7.65 and its 200-day moving average price is $8.59.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reiterated a "buy" rating and set a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st.

Insider Buying and Selling at Arteris

In other news, CFO Nicholas B. Hawkins sold 5,638 shares of the stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $9.50, for a total value of $53,561.00. Following the completion of the transaction, the chief financial officer now owns 156,299 shares of the company's stock, valued at approximately $1,484,840.50. This represents a 3.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO K Charles Janac sold 7,150 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total value of $50,908.00. Following the completion of the transaction, the chief executive officer now owns 318,117 shares of the company's stock, valued at approximately $2,264,993.04. The trade was a 2.20% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 56,533 shares of company stock valued at $418,871. 29.10% of the stock is currently owned by company insiders.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.